期刊文献+

蛋白激酶D抑制剂SD-208对非小细胞肺癌细胞增殖及凋亡的影响 被引量:2

Effect of protein kinase D inhibitor SD-208 on the proliferation and apoptosis of non-small cell lung cancer cells
下载PDF
导出
摘要 目的探讨蛋白激酶D抑制剂SD-208对非小细胞肺癌细胞增殖、凋亡及细胞周期的影响。方法采用5、10、20、30μmol/L SD-208处理非小细胞肺癌细胞A549(设不加SD-208仅添加完全培养基组为对照组),分别在24、48、72 h 3个不同刺激时间点应用四甲基偶氮唑盐比色(MTT)法检测A549细胞的吸光值并计算增殖抑制率;膜联蛋白V-异硫氰酸荧光素(Annexin V-FITC)和碘化丙啶(PI)双染色法结合流式细胞术检测不同浓度SD-208处理A549细胞24、48 h后的细胞凋亡情况,PI染色法流式细胞仪检测分析不同浓度SD-208处理A549细胞48 h后细胞周期时相分布情况;Western blotting检测不同浓度SD-208处理48 h后的细胞周期蛋白A(Cyclin A)、Cyclin D1、Cyclin E、细胞周期蛋白依赖性激酶4(CDK4)和p16蛋白的表达水平。结果 SD-208可抑制A549细胞的增殖,且呈剂量和时间依赖性(P<0.05);SD-208处理后A549细胞的凋亡率及G0/G1期细胞比例均高于对照组,而S、G2/M期细胞比例均低于对照组,各浓度间的差异均有统计学意义(P<0.05);与对照组比较,SD-208处理后的Cyclin D1和CDK4蛋白水平降低,p16蛋白水平升高,差异均有统计学意义(P<0.05)。SD-208处理对A549细胞Cyclin A和Cyclin E蛋白水平无影响,与对照组比较差异无统计学意义(P>0.05)。结论 SD-208可抑制A549细胞增殖并诱导细胞凋亡及G0/G1期阻滞,其机制可能与其影响细胞周期及相关调控蛋白水平有关。 Objective To investigate the effect of protein kinase D inhibitor SD-208 on the proliferation, apoptosis and cell cycle of non-small cell lung cancer cells. Methods The A549 cells were treated with different concentrations of SD-208 (5, 10, 20, 30 μmol/L) , and the cells treated with only complete culture was used as the control group. MTT method was used to detect the absor- banee of A549 cells at 24, 48, and 72 h after treatment and the proliferation inhibition rates were calculated accordingly. Staining with Annexin V-fluorescein isothiocyanate ( Annexin V-FITC) and propidium iodide (PI) was employed to measure the apoptotie rates at 24 and 48 h via flow eytometry. The distribution of cell cycle phase was measured by PI staining after treatment with SD-208 for 48 h. Ex- pression levels of Cyclin A, Cyclin D1, Cyclin E, cyclin dependent kinase 4 (CDK4) and p16 protein were detected by Western blot- ting. Results Compared with the control group, SD-208 could inhibit the proliferation of A549 cells (P〈0. 05 ) , and the effect was exhibited in a dose- and time-dependent manner. As for SD-208 treated groups, apoptotic rates and percentages of G0/Gi phase cells were significantly higher than control group, and the proportion of S and G2/M cells were lower than those in control group ( P〈0. 05 ). Compared with the control group, the levels of CDK4 and Cyclin D1 protein were decreased, and the level of p16 protein was increased after SD-208 treatment with statistical significance ( P〈0.05 ). SD-208 treatment had no effect on the level of Cyelin A and Cyclin E in A549 cells (P〉0.05). Conclusion SD-208 could inhibit the proliferation of A549 cells and induce cell apoptosis and G0/GI phase arrest, which may be related to its effect on cell cycle regulatory proteins.
作者 王稣佳 胡敏
出处 《临床肿瘤学杂志》 CAS 2016年第2期106-110,共5页 Chinese Clinical Oncology
关键词 蛋白激酶D SD-208 非小细胞肺癌 增殖 凋亡 细胞周期 Protein kinase D SD-208 Non-small cell lung cancer(NSCLC) Proliferation Apoptosis Cell cycle
  • 相关文献

参考文献16

  • 1Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010[J]. CA Cancer J Clin, 2010, 60(5) :277-300.
  • 2蔡勇,王季颖.醉茄素A对非小细胞肺癌A549细胞增殖、凋亡及PI3K/Akt信号通路的影响[J].临床肿瘤学杂志,2014,19(2):107-111. 被引量:6
  • 3Tandon M, Johnson J, Li Z, et al. New pyrazolopyrimidine in- hibitors of protein kinase d as potent anticancer agents for prostate cancer cells[ J/OL]. PLoS One, 2013 [ 2015-09-12]. http:// www. ncbi. nlm. nih. gov/pmc/articles/pmid/24086585.
  • 4肖敏,李琛,袁汉尧,刘云岗.鞘氨醇激酶2与蛋白激酶D参与调控丁酸钠诱导的人肝癌细胞凋亡[J].第三军医大学学报,2014,36(3):262-266. 被引量:5
  • 5Wei N, Chu E, Wu SY, et al. The cytotoxic effects of regorafenib in combination with protein kinase D inhibition in human colorectal cancer ceils [ J ]. Oncotarget, 2015, 6 (7) :4745-4756.
  • 6Navarro MN, Goebel J, Hukelmann JL, et al. Quantitative phospho- pmteomics of cytotoxic T cells to reveal protein kinase d 2 regulated networks[J]. Mol Cell Proteomics, 2014, 13(12) :3544-3557.
  • 7Tandon M, Salamoun JM, Carder EJ, et al. SD-208, a novel protein kinase D inhibitor, blocks prostate cancer cell proliferation and tumor growth in vivo by inducing G2/M cell cycle arrest [ J/OL ]. PLoS One, 2015 [ 2015-10-01 ]. http:// www.ncbi.nlm, nih.gov/pmc/articles/pmid/25747583.
  • 8Huck B, Duss S, Hausser A, et al. Elevated protein kinase D3 ( PKD3 ) expression supports proliferation of triple-negative breast cancer cells and contributes to mTORC1-S6K1 pathway activation [J]. J Biol Chem, 2014, 289(6) : 3138-3147.
  • 9Harikumar KB, Kunnumakkara AB, Ochi N, et al. A novel small molecule inhibitor of protein kinase D blocks pancreatic cancer growth in vitro and in vivo [ J ]. Mol Cancer Ther, 2010, 9 (5) : 1136-1146.
  • 10Guo J, Clansen DM, Beumer JH, et al. In vitro eytotoxieity, pharmacokinetics, tissue distribution, and metabolism of small- molecule protein kinase D inhibitors, kb-NB142-70 and kb- NB165-09, in mice bearing human cancer xenografts[ J]. Cancer Chemother Pharmacol, 2013, 71(2): 331-344.

二级参考文献41

  • 1顾星,姚敏,王司晔,时运,董志珍,邱历伟,姚登福.肿瘤坏死因子α/核因子-κB信号通路活化干预对肝癌细胞增殖的抑制作用[J].中华肝脏病杂志,2014,22(6). 被引量:12
  • 2Wlodkowic D,Telford W,Skommer J,et al.Apoptosis and beyond:cytometry in studies of programmed cell death[J].Methods Cell Biol,2011,103:55-98.
  • 3Favaloro B,Allocati N,Graziano V,et al.Role of apoptosis in disease[J].Aging(Albany NY),2012,4(5):330-349.
  • 4Steliou K,Boosalis M S,Perrine SP,et al.Butyrate histone deacety-lase inhibitors[J].Biores Open Access,2012,1(4):192-198.
  • 5Joachimiak R,Kaznica A,Drewa T.Influence of sodium butyrate onhepatocellular carcinoma(hepG2)and glioblastoma(C6)cell lines invitro[J].Acta Pol Pharm,2007,64(6):561-563.
  • 6Xiao M,Liu Y,Zou F.Sensitization of human colon cancer cells to so-dium butyrate-induced apoptosis by modulation of sphingosine kinase 2and protein kinase D[J].Exp Cell Res,2012,318(1):43-52.
  • 7Hait N C,Bellamy A,Milstien S,et al.Sphingosine kinase type 2activation by ERK-mediated phosphorylation[J].J Biol Chem,2007,282(16):12058-12065.
  • 8Yamamoto H,Fujimoto J,Okamoto E,et al.Suppression of growth ofhepatocellular carcinoma by sodium butyrate in vitro and in vivo[J].Int J Cancer,1998,76(6):897-902.
  • 9Sun B,Liu R,Xiao Z D,et al.c-MET protects breast cancer cellsfrom apoptosis induced by sodium butyrate[J].PLoS One,2012,7?1):e30143.
  • 10Rawluszko A A,Slawek S,Gollogly A,et al.Effect of butyrate on aro-matase cytochrome P450 levels in HT29,DLD-1 and LoVo colon canc-er cells[J].Biomed Pharmacother,2012,66(2):77-82.

共引文献17

同被引文献9

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部